Literature DB >> 11905480

Laboratory-acquired meningococcal disease--United States, 2000.

.   

Abstract

Neisseria meningitidis is a leading cause of bacterial meningitis and sepsis among older children and young adults in the United States. N. meningitidis usually is transmitted through close contact with aerosols or secretions from the human nasopharynx. Although N. meningitidis is regularly isolated in clinical laboratories, it has infrequently been reported as a cause of laboratory-acquired infection. This report describes two probable cases of fatal laboratory-acquired meningococcal disease and the results of an inquiry to identify previously unreported cases. The findings indicate that N. meningitidis isolates pose a risk for microbiologists and should be handled in a manner that minimizes risk for exposure to aerosols or droplets.

Entities:  

Mesh:

Year:  2002        PMID: 11905480

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

Review 1.  Laboratory safety practices associated with potential agents of biocrime or bioterrorism.

Authors:  David L Sewell
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.

Authors:  James H Jorgensen; Sharon A Crawford; Kristin R Fiebelkorn
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 3.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 4.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  It's time for a centralized registry of laboratory-acquired infections.

Authors:  Kamaljit Singh
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

Review 6.  Assessing the risk of laboratory-acquired meningococcal disease.

Authors:  James J Sejvar; David Johnson; Tanja Popovic; J Michael Miller; Frances Downes; Patricia Somsel; Robbin Weyant; David S Stephens; Bradley A Perkins; Nancy E Rosenstein
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 7.  Meningococcal glycoconjugate vaccines.

Authors:  Roberto Gasparini; Donatella Panatto
Journal:  Hum Vaccin       Date:  2011-02-01

8.  Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates.

Authors:  James H Jorgensen; Sharon A Crawford; Letitia C Fulcher; Anita Glennen; Susan M Harrington; Jana Swenson; Ruth Lynfield; Patrick R Murray; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

9.  Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage.

Authors:  Hélène Omer; Graham Rose; Keith A Jolley; Eric Frapy; Jean-Ralph Zahar; Martin C J Maiden; Stephen D Bentley; Colin R Tinsley; Xavier Nassif; Emmanuelle Bille
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  Fatal meningococcal disease in a laboratory worker--California, 2012.

Authors:  Channing D Sheets; Kathleen Harriman; Jennifer Zipprich; Janice K Louie; William S Probert; Michael Horowitz; Janice C Prudhomme; Deborah Gold; Leonard Mayer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-05       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.